RT @mvkrier: Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case…
76 followers
1,386 followers
RT @mvkrier: Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case…
222 followers
RT @mvkrier: Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case…
8,952 followers
RT @mvkrier: Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case…